Tagged with MENA

Vaccines While outbreaks of the devastating Ebola virus have – thankfully – generally been highly localized to West Africa, the highly infectious and lethal disease has generated global trepidation due to its characteristic haemorrhagic fever, a 50 percent chance of death on average, and the absence of any approved treatment. The…

Saudi Arabia The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of total sales in the USD 8.2 billion Saudi pharma market. Global giants Pfizer, Sanofi, and Novartis make up the top three spots, but…

Roundup A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access to its COVID-19 vaccine, UAE firm Mubadala’s latest US investment, Saudi Arabia’s continuing digitalisation push, and Algeria’s plan to export USD five billion in domestically…

Medtech Saudi Arabia is seeing an increased demand for more innovative medical devices and a greater awareness of the myriad ways that medical technology can be used for screening illnesses such as cardiovascular disease, cancer and diabetes. Stakeholders from three multinational medtech firms commented on their strategies for growth in this…

Italy Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline Therapeutics by Menarini, research collaboration between Italy and China, labelling regulations, a new biotech sector report and new studies on antibodies against Covid-19.   Menarini gains presence in US oncology market with acquisition of Stemline…

Italy Italy’s pharma industry consistently ranks among the top 10 globally, with domestic companies making up a significant share. These, largely private family-owned firms also have an increasingly global footprint, with international operations now making up a larger portion of their revenues than ever before. See below for the top six…

Italy Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US oncology market through the acquisition of Stemline Therapeutics.   The deal, said to be worth USD 677 million, was announced on 4 May 2020 and completed on 10 June. The acquisition of Stemline,…

UAE Ronald Boueri of Zimmer Biomet Middle East discusses the challenges of establishing the business, the importance of providing the latest innovation and assistance to medical professionals in the MENA (Middle East and North Africa) region, and the need to constantly adapt in the ever-evolving Middle Eastern markets.   Any business…

Morocco Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year double-digit growth for the affiliate ever since. His current priorities include facilitating greater access to innovation within Morocco and bringing Merck’s world-class technological know-how to the country.   Merck has been…

Morocco Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding in 1994 to become the market leader in several therapeutic areas. The company also has an increasingly international footprint, with plans to capture new opportunities in Africa and Europe.   Karim Lahlou, who took…

Morocco Some of the more entrepreneurial Moroccan local laboratories have spotted an opening to leverage their knowledge of Sub Saharan African markets and to act as a conduit and partner for MNCs seeking to break into that region and penetrate those jurisdictions.   The African continent’s potential as a growth market…

UAE Sub-Saharan Africa might not be considered among the top destinations for the global pharmaceutical industry, but Shalina Healthcare considers it home and has established itself as the leading pharma company in the region. Co-CEOs and siblings, Shalina Clifford and Abbas Virji, walk us through the company’s 35-year history of commitment…